Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?
- PMID: 29997392
- PMCID: PMC6752274
- DOI: 10.1038/s41436-018-0097-2
Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- US Food and Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm599560.htm. March 6, 2018.needs an access date
-
- 23andMe Reports Included in Service Access Date: 4/12/2018. https://www.23andme.com/dna-reports-list/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
